- Home
- MBBC vs ATRA Comparison
MBBC vs ATRA Comparison
Compare MBBC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBBC | ATRA |
|---|---|---|
| Founded | 1902 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | MBBC | ATRA |
|---|---|---|
| Price | $13.75 | $4.57 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.2K | ★ 256.0K |
| Earning Date | 05-13-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.11 | ★ $1.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.94 | $3.92 |
| 52 Week High | $14.64 | $19.15 |
Technical Indicators
Market Signals| Indicator | MBBC | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 39.62 |
| Support Level | $12.84 | $4.06 |
| Resistance Level | N/A | $5.80 |
| Average True Range (ATR) | 0.22 | 0.54 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 69.70 | 5.62 |
Price Performance
Historical ComparisonAbout MBBC Marathon Bancorp Inc.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).